Cytokine-related and histological biomarkers for neuropathic pain assessment

2012 ◽  
Vol 2 (4) ◽  
pp. 391-398 ◽  
Author(s):  
Nurcan Üçeyler ◽  
Claudia Sommer
1998 ◽  
Vol 16 (4) ◽  
pp. 775-789 ◽  
Author(s):  
Misha-Miroslav Backonja ◽  
Bradley S. Galer

2019 ◽  
Vol 12 (2) ◽  
pp. e26
Author(s):  
Igor A. Lavrov ◽  
Brian Lundstrom ◽  
Bryan T. Klassen ◽  
Kendall H. Lee ◽  
Squire M. Stead

2004 ◽  
Vol 11 (3) ◽  
pp. 153-162 ◽  
Author(s):  
G. Cruccu ◽  
P. Anand ◽  
N. Attal ◽  
L. Garcia-Larrea ◽  
M. Haanpaa ◽  
...  

Neurosciences ◽  
2018 ◽  
Vol 23 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Esma Ceceli ◽  
Sefa Gümrük ◽  
Müyesser Okumuş ◽  
Seher Kocaoğlu ◽  
Hamit Göksu ◽  
...  

2011 ◽  
Vol 6 (2) ◽  
pp. 128 ◽  
Author(s):  
Nurcan üçeyler ◽  
Claudia Sommer ◽  
◽  

Neuropathic pain is a common and disabling condition that may accompany disorders of the somatosensory system at different anatomical levels. Making the diagnosis of neuropathic pain is a prerequisite for offering the patient specific therapy. In the last few years, the methodological toolbox for the assessment of neuropathic pain has been improved and replenished so that different instruments are available to examine patients and to find out if and to what extent neuropathic pain is present. Currently, three published guidelines are available on the assessment of neuropathic pain. These guidelines are summarised and detailed below, and suggestions are made for future studies investigating known and new methods for the improvement of neuropathic pain assessment.


Sign in / Sign up

Export Citation Format

Share Document